Latest & greatest articles for urinary tract infection

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on urinary tract infection or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on urinary tract infection and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for urinary tract infection

101. Urinary Tract Infection?Child

Urinary Tract Infection?Child Revised2016 ACR Appropriateness Criteria ® 1 Urinary Tract Infection–Child American College of Radiology ACR Appropriateness Criteria ® Urinary Tract Infection–Child Variant 1: Age 2 months and =6 years, first febrile urinary tract infection with good response to treatment. Radiologic Procedure Rating Comments RRL* US kidneys and bladder 7 This procedure has a low yield, especially if US in the third trimester is normal. O Voiding cystourethrography 4 ?? Tc-99m (...) pertechnetate radionuclide cystography 4 ?? Tc-99m DMSA renal cortical scintigraphy 3 ??? Rating Scale: 1,2,3 Usually not appropriate; 4,5,6 May be appropriate; 7,8,9 Usually appropriate *Relative Radiation Level Variant 3: Age >6 years, first febrile urinary tract infection with good response to treatment. Radiologic Procedure Rating Comments RRL* US kidneys and bladder 5 This procedure may be appropriate but there was disagreement among panel members on the appropriateness rating as defined by the panel’s

2016 American College of Radiology

102. Probiotics for preventing urinary tract infections in adults and children. (PubMed)

Probiotics for preventing urinary tract infections in adults and children. Urinary tract infection (UTI) is a common bacterial infection that can lead to significant morbidity including stricture, abscess formation, fistula, bacteraemia, sepsis, pyelonephritis and kidney dysfunction. Mortality rates are reported to be as high as 1% in men and 3% in women due to development of pyelonephritis. Because probiotic therapy is readily available without a prescription, a review of their efficacy

Full Text available with Trip Pro

2015 Cochrane

103. Fosfomycin (Fomicyt) - for the treatment of the following infections in adults and children including neonates: acute osteomyelitis; complicated urinary tract infections; nosocomial lower respiratory tract infections; bacterial meningitis; and bacteraemia

Fosfomycin (Fomicyt) - for the treatment of the following infections in adults and children including neonates: acute osteomyelitis; complicated urinary tract infections; nosocomial lower respiratory tract infections; bacterial meningitis; and bacteraemia Final Appraisal Recommendation Advice No: 3015 – October 2015 Fosfomycin (Fomicyt ® ) 40 mg/ml powder for solution for infusion Limited submission by Nordic Pharma UK Ltd Additional note(s): ? Fosfomycin (Fomicyt ® ) is appropriate (...) within NHS Wales for the treatment of the following infections in adults and children including neonates: acute osteomyelitis; complicated urinary tract infections; nosocomial lower respiratory tract infections; bacterial meningitis; and bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. Fosfomycin (Fomicyt ® ) should be used only when it is considered inappropriate to use antibacterial agents that are commonly recommended

2015 All Wales Medicines Strategy Group

104. Interventions for preventing recurrent urinary tract infection during pregnancy. (PubMed)

Interventions for preventing recurrent urinary tract infection during pregnancy. Recurrent urinary tract infections (RUTI) are common in women who are pregnant and may cause serious adverse pregnancy outcomes for both mother and child including preterm birth and small-for-gestational-age babies. Interventions used to prevent RUTI in women who are pregnant can be pharmacological (antibiotics) or non-pharmacological (cranberry products, acupuncture, probiotics and behavioural modifications). So

Full Text available with Trip Pro

2015 Cochrane

105. Chinese herbal medicine for treating recurrent urinary tract infections in women. (PubMed)

Chinese herbal medicine for treating recurrent urinary tract infections in women. Acute urinary tract infection (UTI) is a common bacterial infection that affects 40% to 50% of women. Between 20% and 30% of women who have had a UTI will experience a recurrence, and around 25% will develop ongoing recurrent episodes with implications for individual well-being and healthcare costs. Prophylactic antibiotics can prevent recurrent UTIs but there are growing concerns about microbial resistance, side (...) using relative risk (RR) for dichotomous outcomes with 95% confidence intervals (CI).We included seven RCTs that involved a total of 542 women; of these, five recruited post-menopausal women (aged from 56 to 70 years) (422 women). We assessed all studies to be at high risk of bias. Meta-analyses comparing the overall effectiveness of treatments during acute phases of infection and rates of recurrence were conducted. Analysis of three studies involving 282 women that looked at CHM versus antibiotics

Full Text available with Trip Pro

2015 Cochrane

106. Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI). (PubMed)

Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI). Treatment of complicated urinary-tract infections is challenging due to rising antimicrobial resistance. We assessed the efficacy and safety of ceftolozane-tazobactam, a novel antibacterial with Gram-negative activity, in the treatment of patients with complicated lower-urinary-tract infections (...) or pyelonephritis.ASPECT-cUTI was a randomised, double-blind, double-dummy, non-inferiority trial done in 209 centres in 25 countries. Between July, 2011, and September, 2013, hospital inpatients aged 18 years or older who had pyuria and a diagnosis of a complicated lower-urinary-tract infection or pyelonephritis were randomly assigned in a 1:1 ratio to receive intravenous 1·5 g ceftolozane-tazobactam every 8 h or intravenous high-dose (750 mg) levofloxacin once daily for 7 days. The randomisation schedule

2015 Lancet

107. Prophylactic antibiotics for children with recurrent urinary tract infections

Prophylactic antibiotics for children with recurrent urinary tract infections Prophylactic antibiotics for urinary tract infections are no longer routinely recommended. A large number of children must be given prophylaxis to prevent one infection and antibiotic resistance is a major concern when treating community-acquired urinary tract infections. The results of three recent significant studies are examined, with focus on the efficacy of prophylaxis, and recommendations are made. Key Words

2015 Canadian Paediatric Society

108. Newborn Male Circumcision for the Prevention of Sexually Transmitted Infections, Urinary Tract Infections, and Cancer

Newborn Male Circumcision for the Prevention of Sexually Transmitted Infections, Urinary Tract Infections, and Cancer Disclaimer: The Rapid Response Service is an information service for those involved in planning and providing health care in Canada. Rapid responses are based on a limited literature search and are not comprehensive, systematic reviews. The intent is to provide a list of sources of the best evidence on the topic that CADTH could identify using all reasonable efforts within (...) Circumcision for the Prevention of Sexually Transmitted Infections, Urinary Tract Infections, and Cancer: Clinical Effectiveness and Guidelines DATE: 6 February 2015 RESEARCH QUESTIONS 1. What is the clinical effectiveness of newborn male circumcision for the prevention of sexually transmitted infections (STIs), urinary tract infections (UTIs), and cancer? 2. What are the evidence-based guidelines regarding the medical indications for newborn male circumcisions? KEY FINDINGS Seven systematic reviews and 16

2015 Canadian Agency for Drugs and Technologies in Health - Rapid Review

109. Treatment of Urinary Tract Infections in the Elderly

Treatment of Urinary Tract Infections in the Elderly Disclaimer: The Rapid Response Service is an information service for those involved in planning and providing health care in Canada. Rapid responses are based on a limited literature search and are not comprehensive, systematic reviews. The intent is to provide a list of sources of the best evidence on the topic that CADTH could identify using all reasonable efforts within the time allowed. Rapid responses should be considered along (...) . It may not be copied, posted on a web site, redistributed by email or stored on an electronic system without the prior written permission of CADTH or applicable copyright owner. Links: This report may contain links to other information available on the websites of third parties on the Internet. CADTH does not have control over the content of such sites. Use of third party sites is governed by the owners’ own terms and conditions. TITLE: Treatment of Urinary Tract Infections in the Elderly: Clinical

2015 Canadian Agency for Drugs and Technologies in Health - Rapid Review

110. Nitrofurantoin for the Treatment of Urinary Tract Infections in Elderly Males

Nitrofurantoin for the Treatment of Urinary Tract Infections in Elderly Males Disclaimer: The Rapid Response Service is an information service for those involved in planning and providing health care in Canada. Rapid responses are based on a limited literature search and are not comprehensive, systematic reviews. The intent is to provide a list of sources of the best evidence on the topic that CADTH could identify using all reasonable efforts within the time allowed. Rapid responses should (...) Infections in Elderly Males: Safety DATE: 3 February 2015 RESEARCH QUESTION What is the clinical evidence regarding the safety of nitrofurantoin in elderly males with urinary tract infections? KEY FINDINGS No literature was identified regarding the safety of nitrofurantoin for the treatment of urinary tract infections in elderly males. References of potential interest are provided in the appendix. METHODS A limited literature search was conducted on key resources including PubMed, The Cochrane Library

2015 Canadian Agency for Drugs and Technologies in Health - Rapid Review

111. Development of Antibiotic Resistance to Norfloxacin in the Treatment of Urinary Tract Infections

Development of Antibiotic Resistance to Norfloxacin in the Treatment of Urinary Tract Infections Disclaimer: The Rapid Response Service is an information service for those involved in planning and providing health care in Canada. Rapid responses are based on a limited literature search and are not comprehensive, systematic reviews. The intent is to provide a list of sources of the best evidence on the topic that CADTH could identify using all reasonable efforts within the time allowed. Rapid (...) Resistance to Norfloxacin in the Treatment of Urinary Tract Infections: Clinical Evidence DATE: 5 February 2015 RESEARCH QUESTION What is the clinical evidence on the development of antibiotic resistance to norfloxacin in the treatment of urinary tract infections (UTIs)? KEY FINDINGS One non-randomized study was identified regarding the development of antibiotic resistance to norfloxacin in the treatment of urinary tract infections. METHODS A limited literature search was conducted on key resources

2015 Canadian Agency for Drugs and Technologies in Health - Rapid Review

112. Avycaz (ceftazidime-avibactam) - To treat adults with complicated intra-abdominal infections (cIAI), in combination with metronidazole, and complicated urinary tract infections (cUTI), including kidney infections (pyelonephritis), who have limited or no a

Avycaz (ceftazidime-avibactam) - To treat adults with complicated intra-abdominal infections (cIAI), in combination with metronidazole, and complicated urinary tract infections (cUTI), including kidney infections (pyelonephritis), who have limited or no a Drug Approval Package: Brand Name (Generic Name) NDA # Drug Approval Package U.S. Food & Drug Administration Search FDA Drug Approval Package - AVYCAZ (ceftazidime-avibactam) Injection Company: Forest Research Institute, Inc. Application

2015 FDA - Drug Approval Package

113. Randomised controlled trial: Cranberry capsules (2 taken twice daily for an average 38?days) reduce the risk of postoperative urinary tract infection in women undergoing benign gynaecological surgery involving intraoperative catheterisation

Randomised controlled trial: Cranberry capsules (2 taken twice daily for an average 38?days) reduce the risk of postoperative urinary tract infection in women undergoing benign gynaecological surgery involving intraoperative catheterisation Cranberry capsules (2 taken twice daily for an average 38 days) reduce the risk of postoperative urinary tract infection in women undergoing benign gynaecological surgery involving intraoperative catheterisation | BMJ Evidence-Based Medicine We use cookies (...) Username * Password * your user name or password? You are here Cranberry capsules (2 taken twice daily for an average 38 days) reduce the risk of postoperative urinary tract infection in women undergoing benign gynaecological surgery involving intraoperative catheterisation Article Text Therapeutics/Prevention Randomised controlled trial Cranberry capsules (2 taken twice daily for an average 38 days) reduce the risk of postoperative urinary tract infection in women undergoing benign gynaecological

2015 Evidence-Based Medicine (Requires free registration)

114. Urinalysis and urine culture specimens taken from old versus new urinary catheters in patients with suspected urinary tract infection

Urinalysis and urine culture specimens taken from old versus new urinary catheters in patients with suspected urinary tract infection Urinalysis and urine culture specimens taken from old versus new urinary catheters in patients with suspected urinary tract infection Urinalysis and urine culture specimens taken from old versus new urinary catheters in patients with suspected urinary tract infection Mitchell MD, O'Donnell JA, Pegues DA, Umscheid CA Record Status This is a bibliographic record (...) of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Mitchell MD, O'Donnell JA, Pegues DA, Umscheid CA. Urinalysis and urine culture specimens taken from old versus new urinary catheters in patients with suspected urinary tract infection. Philadelphia: Center for Evidence-based Practice (CEP). 2014 Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Humans; Urinalysis; Urinary Catheters; Urinary Tract

2014 Health Technology Assessment (HTA) Database.

115. Urinary tract infection in infants and children: Diagnosis and management

Urinary tract infection in infants and children: Diagnosis and management Recent studies have resulted in major changes in the management of urinary tract infections (UTIs) in children. The present statement focuses on the diagnosis and management of infants and children >2 months of age with an acute UTI and no known underlying urinary tract pathology or risk factors for a neurogenic bladder. UTI should be ruled out in preverbal children with unexplained fever and in older children (...) with symptoms suggestive of UTI (dysuria, urinary frequency, hematuria, abdominal pain, back pain or new daytime incontinence). A midstream urine sample should be collected for urinalysis and culture in toilet-trained children; others should have urine collected by catheter or by suprapubic aspirate. UTI is unlikely if the urinalysis is completely normal. A bagged urine sample may be used for urinalysis but should not be used for urine culture. Antibiotic treatment for seven to 10 days is recommended

2014 Canadian Paediatric Society

116. Monitoring in vitro antibacterial efficacy of 26 Indian spices against multidrug resistant urinary tract infecting bacteria (PubMed)

Monitoring in vitro antibacterial efficacy of 26 Indian spices against multidrug resistant urinary tract infecting bacteria To screen methanolic extracts of 26 commonly used Indian spices against nine species of uropathogenic bacteria (Enterococcus faecalis, Staphylococcus aureus, Acinetobacter baumannii, Citrobacter freundii, Enterobacter aerogenes, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, and Pseudomonas aeruginosa), isolated from clinical samples of a tertiary care

Full Text available with Trip Pro

2014 Integrative medicine research

117. Urinary Tract Infections in Older Women (PubMed)

Urinary Tract Infections in Older Women 24570259 2014 03 03 2016 10 25 1538-3598 311 8 2014 Feb 26 JAMA JAMA JAMA patient page. Urinary tract infections in older women. 874 10.1001/jama.2014.1152 Mody Lona L Juthani-Mehta Manisha M eng R01 AG032298 AG NIA NIH HHS United States R01 AG041780 AG NIA NIH HHS United States Patient Education Handout United States JAMA 7501160 0098-7484 AIM IM Aged Female Humans Urinary Tract Infections complications diagnosis drug therapy etiology prevention

Full Text available with Trip Pro

2014 JAMA

118. Recurrent Lower Urinary Tract Infections in Women

Recurrent Lower Urinary Tract Infections in Women Date of origin: 1995 Last review date: 2014 ACR Appropriateness Criteria ® 1 Recurrent Lower UTIs in Women American College of Radiology ACR Appropriateness Criteria ® Clinical Condition: Recurrent Lower Urinary Tract Infections in Women Variant 1: “Uncomplicated” with no underlying risk factors. Radiologic Procedure Rating Comments RRL* CT abdomen and pelvis without and with IV contrast 2 ???? X-ray abdomen 2 ?? CT abdomen and pelvis without IV (...) appropriate *Relative Radiation Level ACR Appropriateness Criteria ® 2 Recurrent Lower UTIs in Women Clinical Condition: Recurrent Lower Urinary Tract Infections in Women Variant 2: “Complicated,” or patients who are nonresponders to conventional therapy, get frequent reinfections or relapses, and have known underlying risk factors. (See Appendix 1.) Radiologic Procedure Rating Comments RRL* CT abdomen and pelvis without and with IV contrast 7 CT urography protocol is preferred. If enterovesical fistulas

2014 American College of Radiology

119. Urinary tract infection - children

Urinary tract infection - children Urinary tract infection - children - NICE CKS Clinical Knowledge Summaries Share Urinary tract infection - children: Summary Urinary tract infection (UTI) is illness caused by micro-organisms in the urinary tract. Most UTIs are caused by bacteria from the gastrointestinal tract. Common organisms causing UTI in children include Escherichia coli (about 85% or more of cases), Klebsiella species, and Staphylococcus saprophyticus . At least 8% of girls and 2 (...) unwell after 24–48 hours of treatment or if they suspect a repeat UTI). Have I got the right topic? Have I got the right topic? From birth to 16 years. This CKS topic is based on the National Institute for Health and Care Excellence guideline Urinary tract infection in children: diagnosis, treatment and long-term management [ ]. This CKS topic covers the management in primary care of urinary tract infection (UTI) in infants and children. This CKS topic does not cover the management of recurrent UTI

2014 NICE Clinical Knowledge Summaries

120. Urinary tract infection (lower) - men

Urinary tract infection (lower) - men Urinary tract infection (lower) - men - NICE CKS Clinical Knowledge Summaries Share Urinary tract infection (lower) - men: Summary Urinary tract infection (UTI) is infection of any part of the urinary tract, usually by bacteria. The commonest uropathogen causing UTI in adults is Escherichia coli in approximately 80% of cases. UTI in men is generally uncommon, but incidence rates are higher in elderly men and those with risk factors, such as: Benign (...) prostatic hypertrophy (BPH) and other causes of urine outflow obstruction (for example, urinary tract stones, urethral stricture). Catheterisation — UTI is the most common hospital acquired infection, and the majority of cases result from indwelling catheters. Previous urinary tract surgery. Immunocompromised state. Complications may include: Renal function impairment. Prostatitis. Pyelonephritis. Sepsis. Urinary stones. A lower UTI should be suspected if the man has: Dysuria, frequency, urgency

2014 NICE Clinical Knowledge Summaries